ABBVIE
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Drug Manufacturers - General
業務概覽 AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan addedseveral new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
公司地址 1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
電話號碼 +1 847 932-7900
傳真號碼 --
公司網頁 https://www.abbvie.com
員工數量 57000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. David R. Purdue Principal Accounting Officer, Senior Vice President and Controller -- 20/02/2026
Mr. Demetris D. Crum Executive Vice President and Chief Human Resources Officer -- 20/02/2026
Dr. Roopal Thakkar, M.D. Executive Vice President, Research and Development and Chief Scientific Officer -- 20/02/2026
Dr. Azita Saleki-Gerhardt, B.S.,M.S.,PhD Executive Vice President and Chief Operations Officer 美元 1.02M 20/02/2026
Dr. Nicholas J. Donoghoe, M.D. Executive Vice President, Chief Business and Strategy Officer -- 20/02/2026
Mr. Robert A. Michael Chairman of the Board and Chief Executive Officer 美元 1.61M 20/02/2026
Mr. Jeffrey Ryan Stewart Executive Vice President and Chief Commercial Officer 美元 1.28M 20/02/2026
Mr. Scott T. Reents Executive Vice President and Chief Financial Officer 美元 1.07M 20/02/2026
Mr. Perry C. Siatis Executive Vice President, General Counsel and Secretary -- 20/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Frederick H. Waddell Independent Director 20/02/2026
Ms. Rebecca B. Roberts Independent Director 20/02/2026
Dr. Robert J. Alpern,M.D. Independent Director 20/02/2026
Mr. Thomas C. Freyman Independent Director 20/02/2026
Mr. Edward J. Rapp Independent Director 20/02/2026
Dr. Susan E. Quaggin, M.D. Independent Director 20/02/2026
Ms. Roxanne S. Austin Lead Independent Director 20/02/2026
Mr. Brett J. Hart Independent Director 20/02/2026
Mr. William H.L. Burnside Independent Director 20/02/2026
Ms. Melody B. Meyer Independent Director 20/02/2026
Mr. Robert A. Michael Chairman of the Board and Chief Executive Officer 20/02/2026
Mr. Thomas J. Falk Independent Director 20/02/2026
Ms. Jennifer L. Davis Independent Director 20/02/2026
 
所屬ETF (更新日期: 07/03/2026 04:13)
代號 名稱 佔比% ▼ 持有日期
BKLCBNY Mellon US Large Cap Core Equity ETF0.01%28/02/2026
PBPHPortfolio Bldg Blck Wld Phrm &BtchIdxETF0.01%26/02/2026
VTHRVanguard Russell 3000 ETF0.01%31/01/2026
CSQCalamos Strategic Total Return0.01%31/12/2025
RECSColumbia Research Enhanced Core ETF0.01%04/02/2026
SSOProShares Ultra S&P5000.01%27/02/2026
CGCVCapital Group Conservative Equity ETF0.01%31/01/2026
SCHKSchwab 1000 ETF0.01%28/02/2026
USCAXtrackers MSCI USA Clmt Actn Eq ETF0.01%26/02/2026
EVTEV Tax Advantaged Dividend Inc0.01%31/12/2025
SPXLDirexion Daily S&P500® Bull 3X ETF0.01%26/02/2026
FLQLFranklin US Large Cap Mltfctr Idx ETF0.01%28/02/2026
EOSEV Enhanced Equity Income II0.01%31/12/2025
LRGFiShares U.S. Equity Factor ETF0.01%28/02/2026
FBCGFidelity Blue Chip Growth ETF0.01%31/01/2026
SDOGALPS Sector Dividend Dogs ETF0.01%28/02/2026
RWLInvesco S&P 500 Revenue ETF0.01%27/02/2026
SNPEXtrackers S&P 500 Scrd & Scrn ETF0.01%26/02/2026
ABFLAbacus FCF Leaders ETF0.01%27/02/2026
USCLiShares Climate Conscious &TrnMSCIUSAETF0.01%28/02/2026
  1    2    3    4   5    6    7    8    9    10    11    12    13    14    15    16    17    18    19    20    21    22    23    24    25  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.